Ocimum Biosolutions - Board of Directors

Board of Directors

Ms. Anuradha Acharya, Founder & CEO of Ocimum Biosolutions

Ms. Acharya is the founder CEO of Ocimum Biosolutions, an innovative life sciences R&D enabling company. The company was founded in the year 2000 and boasts of 2 European acquisitions, GD business of MWG Biotech of Germany and the BioMolecules Division of Isogen Life Sciences from The Netherlands. Ocimum today has over 2000 customers worldwide and operates under 3 main business units of BioIT, BioMolecules and BioResearch. Ocimum was recently funded by the International Finance Corporation (IFC), the private Equity arm of the World Bank.

Prior to founding Ocimum Biosolutions with two other partners, Subash Lingareddy and Dr. Sujata Pammi, Ms.Acharya has had rich experience in the Telecom, IT and entrepreneurship arenas. She worked for a startup in the telecommunications space called Mantiss Information and a consulting firm called SEI Information where she helped create a social networking site for entrepreneurs. Both Mantiss and SEI were based in Chicago, IL. Her experience is backed by education at premier institutions like the Indian Institute of Technology at Kharagpur, India (IIT) and University of Illinois where she has two Post Graduate degrees in Physics and MIS.

She is a regular in technology forums and round tables and one of the well known first generation entrepreneurs in the Indian life-sciences space. She was named by Red Herring Magazine to the list of "25 Tech Titans under 35" in 2006. Ocimum has received several awards including "Fastest Growing Life Sciences Company in India", "IT Innovation Award" by NASSCOM and has been named to the Deloitte list of Fastest Growing companies in Asia, three years in a row.

Dr. P. Sujata, PhD, Founder & CSO of Ocimum Biosolutions

Dr. Sujata has done post-doctoral work in Université de Perpignan, France, and has over 15 years of experience in Molecular Biology and Biotechnology. She has also worked on DNA sequencing and Genome mapping at Texas A&M University, USA, and has Biotechnology and Functional Bioinformatics experience at one of the largest life sciences companies in the US.

Mr. Subash Lingareddy, Founder & CFO of Ocimum Biosolutions

Mr. Subash Lingareddy is a Financial Professional and a CFA charter holder with over six years of experience working in several roles from an equity analyst to a financial risk manager, before joining Ocimum. He has an MBA from the University of Illinois at Urbana Champaign with a concentration in Corporate Finance. He has a MS in Financial Mathematics from the University of Chicago specializing in risk management. He has a Bachelors degree in Physics from the Indian Institute of Technology at Kharagpur.

Mr. G.V. Prasad, CEO of Dr. Reddy's Laboratories

Mr. G.V. Prasad is serving as an independent director on board of Ocimum Biosolutions. Apart from this, he leads the core team that drives Dr. Reddy Laboratory's growth and transformation from a company predominantly selling API, Branded Formulations and Generics to achieving its vision of becoming a discovery-led global pharmaceutical company.

As CEO of Dr. Reddy's Laboratories, Mr. Prasad has championed its globalization and has played a vital role in the company's evolution. He has been the architect of the company's global generics strategy. He has helped create new platforms of growth for Dr. Reddy's, in the Custom Pharmaceutical Services, Discovery Services and Specialty Pharmaceutical segments. Currently, his focus is on driving Dr. Reddy's growth in two of the world's biggest markets – US and Europe.

Mr. Prasad has a Bachelors degree in Chemical Engineering from Illinois Institute of Technology, Chicago and a Masters in Industrial Administration from Purdue University.

Mr. B.V.R. Mohan Reddy, Chairman and MD of InfoTech Enterprises Ltd.

Mr. B.V.R. Mohan Reddy is serving as an independent director on board of Ocimum Biosolutions. He is acknowledged to have pioneered the CAD/CAM culture in India and has over thirty years of engineering and management experience, most of it in the IT industry. Apart from being at the helm of affairs of Infotech, as its Chairman and Managing Director, he also serves as Member on the Executive Council of NASSCOM and on Advisory Councils of many institutions. Mr. Reddy has led many initiatives with his forethought and vision for the benefit of the IT Industry, in particular, with his involvement with associations like CII, NASSCOM, HYSEA, ELIAP etc.

Mr. Reddy is a graduate in Mechanical Engineering and has two Masters' degrees – one in Management Engineering from the University of Michigan, Ann Arbor, USA and another in Industrial Engineering from the Indian Institute of Technology (IIT), Kanpur.

Ms. Anula Jayasurya, Co-founder and Managing Director of the Evolvence India Life Science Fund (EILSF).

Ms. Anula Jayasurya is serving as an independent director on board of Ocimum Biosolutions. She is the Co-founder and Managing Director of the Evolvence India Life Science Fund (EILSF). Was also a VP-Corporate development at Genomics Collaborative Inc. and a Vice President, for Global Drug Development at Hoffman-La Roche. Also served as a partner with Skyline Ventures in Palo Alto and with TVM, a German- US venture capital firm in San Francisco.

She is also serving on boards for Health Care Global (Bangalore), and Lipomics Technologies (Sacramento, CA). Also a non-profit board director for Astia, LPFI, Harvard Business School Health Industry Alum, Gruter Institute for Law and Behavioral Research.

Ms. Jayasurya has done her BA from Harvard Summa cum Laude, MD and PhD (in Microbiology and Molecular Genetics) from Harvard Medical School, Interned in Pediatrics at Boston Children’s Hospital, MBA with distinction from Harvard Business School and M.Phil in pharmacology from the University of Cambridge, England.

Mr. Mario Gobbo, Managing Director at Natexis Bleichroder.

Mr. Mario Gobbo is serving as an independent director on board of Ocimum Biosolutions. He has 23 years of banking experience spanning pharmaceuticals, biotechnology, oil and gas, telecommunications, power and financial institutions. Mr. Gobbo is the Managing Director at Natexis Bleichroder. He is also in charge of life sciences investments for IFC, a World Bank Group institution dealing with private sector investments. Also managed Central and Eastern European practice for Lazard Brothers in London.

He had a rewarding career with Continental Illinois National Bank, Swiss Bank Corporation International Ltd. and other reputed financial institutions. In the field of biotech and pharma, he worked on initial public offering of Ares Serono, Now Serono, the largest European biotech company, and of Pliva from Croatia, the most prominent pharma company in Central Europe.

Mr. Gobbo has done his BA from Harvard College, M Sc from University of Colorado, MBA, Master of Business Economics and a PhD(Management) from Wharton School of the University of Pennsylvania.

Mr. Ramanan Raghavendran, Managing Partner at Kubera Partners.

Ramanan Raghavendran founded Kubera in December 2006 together with Kumar Mahadeva.

Prior to founding Kubera, he was responsible for leading the successful cross-border investing efforts at TH Lee Putnam Ventures (THLPV) as a Senior Partner and continues to oversee the THLPV portfolio today.

Ramanan was formerly a Senior Partner at Insight Venture Partners where he invested in business process outsourcing and enterprise software companies, including cross-border investing via Connect Capital, an Insight affiliate. Prior to joining Insight, he was a senior member of the investment team at General Atlantic where he initiated the Internet-related investment effort and also led sector efforts in technology services and enterprise software. Ramanan began his career at McKinsey & Company.

Ramanan is the chairman of the advisory board of Magic Bus, a Mumbai-based charitable organization that uses innovative techniques to assist some of the most at-risk children in Mumbai. He is a member of the advisory board of the Center for the Advanced Study of India at the University of Pennsylvania, the only research institution in the United States dedicated to the study of contemporary India. Ramanan also co-founded Impact Partners, the first venture philanthropy entity in India.

Ramanan holds a BSc in Finance from the University of Pennsylvania's Wharton School and a BSE in Computer Science from the University of Pennsylvania's Moore School of Engineering.

Mr. Abhishek Maheshwari, Principal at Kubera Partners.

Abhishek Maheshwari is a Principal with Kubera Partners located in their Mumbai office. Abhishek leads Kubera’s deal and portfolio activities in India.

Prior to joining Kubera, Abhishek was an Engagement Manager with McKinsey & Co. at their Mumbai and Stamford offices. While at McKinsey, he led several strategy and operations engagements across technology, telecommunications and industrial sectors for clients in India, US and Europe. Prior to McKinsey, he was a team leader at Cambridge Technology Partners in their Frankfurt office and led several system implementation projects across Europe.

Abhishek received an MBA with distinction from Columbia Business School and a BS in Electrical Engineering from the Indian Institute of Technology, New Delhi.


	An ISO 9001:2000 Company